Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Monolithic Power Systems Inc (MPWR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Monolithic Power Systems Inc — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B), while Monolithic Power Systems Inc trades at $1,386.29 (market cap $67.32B). The key difference: Monolithic Power Systems Inc is far larger — about 11.1× Iovance Biotherapeutics Inc. Common Stock's market cap, and Monolithic Power Systems Inc pays a 0.58% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Monolithic Power Systems Inc for 25 Days on average.
| IOVA | MPWR | |
|---|---|---|
Market Cap | $6.04B | $67.32B |
Volume | 14,805,993 | 826,960 |
Sector | Health | Technology |
52-Week High | $14.82 | $1.69K |
52-Week Low | $1.81 | $856.96 |
Typical Hold Time | 0 Days | 25 Days |
Enterprise Value | $5.97B | $65.92B |
Dividend Yield | — | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Monolithic Power Systems (MPWR) trades at $1,386.29, down 2.78% on the day, with strong technical momentum indicated by a bullish moving average signal. The company demonstrates robust fundamentals with Q2 2026 EPS beating expectations at $6.50 versus $5.87, and maintains healthy profitability with a 24.5% net income margin. Recent developments include a manufacturing partnership with GlobalFoundries to scale power solutions for AI and data centers.
The outlook remains positive with 88% analyst buy ratings and a consensus price target of $1,830 representing 32% upside. Key risks include premium valuation multiples (P/E 83.58) and potential margin pressure from competitive markets. Earnings growth driven by AI infrastructure demand remains the primary catalyst for continued stock appreciation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Monolithic Power Systems Inc
Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.
Read more on MPWR →
